Salarius Announces Pricing of $5.3 Million Underwritten Public Offering Back Salarius Announces Pricing of $5.3 Million Underwritten Public Offering Read More
Salarius Announces Proposed Public Offering of Common Stock Back Salarius Announces Proposed Public Offering of Common Stock Read More
Salarius Pharmaceuticals to Expand Clinical Program to Target Additional Sarcomas in Ewing Sarcoma Phase 1/2 Clinical Trial Back Salarius Pharmaceuticals to Expand Clinical Program to Target Additional Sarcomas in Ewing Sarcoma Phase 1/2 Clinical Trial Read More
Salarius Pharmaceuticals Announces Move to New Corporate Offices at Texas Medical Center Back Salarius Pharmaceuticals Announces Move to New Corporate Offices at Texas Medical Center Read More
Salarius Pharmaceuticals Names Nadeem Mirza, M.D., M.P.H., as Senior Vice President Clinical Development Back Salarius Pharmaceuticals Names Nadeem Mirza, M.D., M.P.H., as Senior Vice President Clinical Development Read More